These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2272812)

  • 21. [Treatment and prophylaxis of an acute migraine attack].
    Diener HC; Gendolla A
    MMW Fortschr Med; 2004 Sep; 146(35-36):41, 43-5. PubMed ID: 15540539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The enigma of site of action of migraine preventives: no effect of metoprolol on trigeminal pain processing in patients and healthy controls.
    Hebestreit JM; May A
    J Headache Pain; 2017 Dec; 18(1):116. PubMed ID: 29285569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [[Effect of migraine medications on monocyte chemotaxis] ].
    Krumholz W; Szalay G; Ogal H; Menges T
    Anaesthesiol Reanim; 2000; 25(4):102-4. PubMed ID: 11132397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mild analgesics as an alternative to ergotamine in migraine. A comparative trial with acetylsalicylic acid, ergotamine tartrate, and a dextropropoxyphene compound.
    Hakkarainen H; Quiding H; Stockman O
    J Clin Pharmacol; 1980 Oct; 20(10):590-5. PubMed ID: 7440766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylsalicylic acid effervescent 1000 mg (Aspirin) in acute migraine attacks; a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study.
    Lange R; Schwarz JA; Hohn M
    Cephalalgia; 2000 Sep; 20(7):663-7. PubMed ID: 11128825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metoprolol, a new effective antimigraine agent].
    Raveau-Landon C; Bousser MG
    Presse Med; 1988 Oct; 17(35):1805-9. PubMed ID: 2978324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks.
    Diener HC; Bussone G; de Liano H; Eikermann A; Englert R; Floeter T; Gallai V; Göbel H; Hartung E; Jimenez MD; Lange R; Manzoni GC; Mueller-Schwefe G; Nappi G; Pinessi L; Prat J; Puca FM; Titus F; Voelker M;
    Cephalalgia; 2004 Nov; 24(11):947-54. PubMed ID: 15482357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group.
    Diener HC
    Cephalalgia; 1999 Jul; 19(6):581-8; discussion 542. PubMed ID: 10448545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin prophylaxis in migraine.
    O'Neill BP; Mann JD
    Lancet; 1978 Dec; 2(8101):1179-81. PubMed ID: 82144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results of migraine prophylaxis with flunarizine and beta-blockers.
    Wöber C; Wöber-Bingöl C; Koch G; Wessely P
    Cephalalgia; 1991 Dec; 11(6):251-6. PubMed ID: 1790569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
    Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
    Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks.
    Le Jeunne C; Gómez JP; Pradalier A; Titus i Albareda F; Joffroy A; Liaño H; Henry P; Lainez JM; Geraud G
    Eur Neurol; 1999 Jan; 41(1):37-43. PubMed ID: 9885327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metoprolol in the prophylaxis of migraine: parallel-groups comparison with placebo and dose-ranging follow-up.
    Steiner TJ; Joseph R; Hedman C; Rose FC
    Headache; 1988 Feb; 28(1):15-23. PubMed ID: 3277926
    [No Abstract]   [Full Text] [Related]  

  • 34. Central mechanisms of controlled-release metoprolol in migraine: a double-blind, placebo-controlled study.
    Siniatchkin M; Andrasik F; Kropp P; Niederberger U; Strenge H; Averkina N; Lindner V; Stephani U; Gerber WD
    Cephalalgia; 2007 Sep; 27(9):1024-32. PubMed ID: 17680819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
    Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
    Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study.
    van de Ven LL; Franke CL; Koehler PJ
    Cephalalgia; 1997 Aug; 17(5):596-9. PubMed ID: 9251876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind comparison of an acetaminophen 400 mg-codeine 25 mg combination versus aspirin 1000 mg and placebo in acute migraine attack.
    Boureau F; Joubert JM; Lasserre V; Prum B; Delecoeuillerie G
    Cephalalgia; 1994 Apr; 14(2):156-61. PubMed ID: 8062355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose aspirin for migraine prophylaxis.
    Buring JE; Peto R; Hennekens CH
    JAMA; 1990 Oct; 264(13):1711-3. PubMed ID: 2204739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No effect of prophylactic treatment with metoprolol on cerebrovascular CO2 reactivity in migraineurs.
    Kastrup A; Thomas C; Hartmann C; Schabet M
    Cephalalgia; 1998; 18(6):353-7. PubMed ID: 9731941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.